This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In a recently published article, Lower et al¹ describe their "experience of the manifestations, clinical outcome, and treatment regimens in patients with neurological sarcoidosis." Their definition of neurosarcoidosis includes "non-caseating granulomas in neurological tissue" as well as neurological abnormalities in patients diagnosed as having nonneurological sarcoidosis. However, the authors neglect to include in their criteria for neurosarcoidosis the presence of evoked potential abnormalities. Several studies have documented visual, auditory, and/or somatosensory evoked potential abnormalities in patients with neurosarcoidosis.^2-6 In one of these studies, 5 of 12 patients had evoked potential abnormalities in the absence of clinical signs of neurosarcoidosis.⁶ This suggests that neurosarcoidosis may be subclinical and more common than would otherwise be assumed. I would suggest that studies evaluating the response of neurosarcoidosis to treatment include an assessment of multimodality evoked potential abnormalities and the evolution of such abnormalities with treatment.

Michael R. Simon, MD, FACP
Veterans Affairs Medical . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?